» Articles » PMID: 20008542

Oxidative/nitrosative Stress Selectively Altered A(2B) Adenosine Receptors in Chronic Obstructive Pulmonary Disease

Abstract

The primary aim of this study was to investigate adenosine receptors (ARs) in bronchoalveolar lavage (BAL) macrophages from patients with chronic obstructive pulmonary disease (COPD) and age-matched healthy smokers. A(2B)ARs were significantly decreased in BAL macrophages from patients with COPD when compared with healthy smokers. The effect of proinflammatory cytokines and oxidative/nitrosative stress on AR expression and function in U937 cells before and after PMA treatment was evaluated. IL-1beta and TNF-alpha treatment up-regulated A(2A)- and A(3)ARs but not A(1)- or A(2B)ARs, whereas IL-6 did not modify AR expression. In contrast, oxidative/nitrosative stress selectively decreased A(2B)AR expression, which was associated with a reduction in the potency of the adenosine agonist 5'-N-ethylcarboxamideadenosine (NECA) to induce cAMP. Further, the ability of NECA to enhance cell proliferation was increased after oxidative/nitrosative stress. The specific involvement of A(2B)ARs was investigated by using potent and selective A(2B)AR antagonist and by A(2B)AR knockdown using siRNA and demonstrated responses similar to those obtained with oxidative/nitrosative stress. N-acetylcysteine (NAC), an antioxidant agent, counteracted the decrease in A(2B)AR expression, as well as the altered NECA effects on cAMP and cell proliferation. These findings highlight the central role of A(2B)ARs in alveolar macrophages, suggesting that their modulation could represent an innovative pharmacological strategy to manage COPD.-Varani, K., Caramori, G., Vincenzi, F., Tosi, A., Barczyk, A., Contoli, M., Casolari, P., Triggiani, M., Hansel, T., Leung, E., MacLennan, S., Barnes, P. J., Fan Chung, K., Adcock, I., Papi, A., Borea, P. A. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.

Citing Articles

Inflammation resolution in environmental pulmonary health and morbidity.

Marzec J, Nadadur S Toxicol Appl Pharmacol. 2022; 449:116070.

PMID: 35618031 PMC: 9872158. DOI: 10.1016/j.taap.2022.116070.


Adenosine and Inflammation: Here, There and Everywhere.

Pasquini S, Contri C, Borea P, Vincenzi F, Varani K Int J Mol Sci. 2021; 22(14).

PMID: 34299305 PMC: 8304851. DOI: 10.3390/ijms22147685.


The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Antonioli L, Blandizzi C, Pacher P, Hasko G Pharmacol Rev. 2019; 71(3):345-382.

PMID: 31235653 PMC: 6592405. DOI: 10.1124/pr.117.014878.


TRPC6 channel translocation into phagosomal membrane augments phagosomal function.

Riazanski V, Gabdoulkhakova A, Boynton L, Eguchi R, Deriy L, Hogarth D Proc Natl Acad Sci U S A. 2015; 112(47):E6486-95.

PMID: 26604306 PMC: 4664321. DOI: 10.1073/pnas.1518966112.


The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.

Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S PLoS One. 2012; 7(6):e39317.

PMID: 22761760 PMC: 3382599. DOI: 10.1371/journal.pone.0039317.